REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
03/30/2026
Back to search
Official data from USPTO
SYNAPSINAE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
47
Latest update
03/31/2026
Classification
Registered
Trademark type
Word
Nice classes
5
Filing date
05/09/2018
Registration date
03/30/2021
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
03/30/2021
Last transaction
03/31/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
Drawing code
4
Owner type
16
Owner location
GRAND CAYMAN, KY
Examiner
LIEBL, ALEXANDRA
Law office
N20
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
S. N. (pessoa física)
SyneuRx International (Taiwan) Corp.
SyneuRx International (Taiwan) Corp.
Representatives
Michael T. Smith BIRCH STEWART KOLASCH & BIRCH LLP
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Therapeutic pharmaceutical for the treatment of neuropsychiatric disordersschizophreniadepressionattention deficit disordermild cognitive impairmentdementiabipolar disorderother central nervous system disorders; Syrups for pharmaceutical purposes for the treatment of ADHD; Chemical preparations for pharmaceutical or medical purposesfor treating neuropsychiatric disordersschizophreniadepressionattention deficit disordermild cognitive impairmentdementiabipolar disorderother central nervous system disorders; Chemical reagents for medical or veterinary purposes; Adjuvants for medical purposes; Animal feed additive for use as a nutritional supplement for medical purposes; Amino acid preparations for medical purposes; Amino acids for medical or veterinary purposes; Amino acids for medical purposes; Beverages containing amino acid for use as a nutritional supplement; Liquid nutritional supplement; Amino acids for nutritional purposes; Dietary and nutritional supplements; Nutritional supplements in the form of capsulestabletscapletspowdersyrupsgummies and gels; Powdered nutritional supplement drink mix; Nutritional supplement meal replacement bars for boosting energy; Nutritional supplements consisting primarily of amino acid; Nutritional supplement shakes; Nutritional and dietary supplements formed and packaged as bars; Nutritional supplements in capsule form for dogs; Nutritional supplements; Nutritionally fortified water for medical purposes; Nutritionally fortified beverages for medical purposes; Vitamin fortified beverages for medical purposes; Vitamin enriched chewing gum for medical purposes; Soy protein for use as a nutritional supplement in various powdered and ready-to-drink beverages; Nutritional supplement in the nature of a nutrient-denseprotein-based drink mix; Powdered nutritional supplement drink mix containing amino acid; Nutritional supplements for catsdogs; Nutraceuticals for use as a dietary supplement for depressed mood; Nutraceuticals for the treatment of CNS disorders; Nutraceuticals for use as a dietary supplement
Publications
History of USPTO decisions and trademark events.
47 publications found
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
01/21/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
03/30/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
01/12/2021
PUBO
PUBLISHED FOR OPPOSITION
01/12/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/23/2020
OTHE
CASE RETURNED TO EXAMINATION
12/09/2020
IUCN
NOTICE OF ALLOWANCE CANCELLED
12/09/2020
ATRQ
ATTORNEY REVIEW/DECISION ON AMENDMENT REQUIRED
12/02/2020
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
12/02/2020
APET
ASSIGNED TO PETITION STAFF
12/01/2020
DOCK
ASSIGNED TO EXAMINER
11/02/2020
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
10/01/2020
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/24/2020
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/24/2020
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/24/2020
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/24/2020
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/24/2020
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/24/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/30/2020
EX3G
SOU EXTENSION 3 GRANTED
05/28/2020
EXT3
SOU EXTENSION 3 FILED
05/28/2020
EEXT
SOU TEAS EXTENSION RECEIVED
05/28/2020
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/05/2019
EX2G
SOU EXTENSION 2 GRANTED
12/03/2019
EXT2
SOU EXTENSION 2 FILED
12/03/2019
EEXT
SOU TEAS EXTENSION RECEIVED
12/03/2019
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
06/11/2019
EX1G
SOU EXTENSION 1 GRANTED
06/07/2019
EXT1
SOU EXTENSION 1 FILED
06/07/2019
EEXT
SOU TEAS EXTENSION RECEIVED
06/07/2019
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
12/25/2018
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/30/2018
PUBO
PUBLISHED FOR OPPOSITION
10/30/2018
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
10/10/2018
ALIE
ASSIGNED TO LIE
09/21/2018
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/06/2018
XAEC
EXAMINER'S AMENDMENT ENTERED
09/06/2018
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
09/06/2018
GNEA
EXAMINERS AMENDMENT E-MAILED
09/06/2018
CNEA
EXAMINERS AMENDMENT -WRITTEN
09/06/2018
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/05/2018
GNRT
NON-FINAL ACTION E-MAILED
09/05/2018
CNRT
NON-FINAL ACTION WRITTEN
09/05/2018
DOCK
ASSIGNED TO EXAMINER
08/30/2018
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/18/2018
NWAP
NEW APPLICATION ENTERED
05/12/2018
Continuous trademark protection
Get notified about every new filing that threatens SYNAPSINAE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.